Notably however, PAD-deficient mice exhibited innate immune dysfunction and were more susceptible to bacterial infections (22), indicating the need to identify another possible trigger of NETs for the development of therapeutic agents for AAA (23). This evidence concerns the gene PADI4 and triple-A syndrome.